Balance Sheet for Medicenna Therapeutics Corp. (MDNA)

$ 3.86   -0.05 (-1.28%) Volume: 59.07k 3:59 PM EST Nov 30, 2020
Statement: View:
Assets [+] in Thousands of Dollars
03/2020 03/2019 03/2018 03/2017 12/2015
Cash and Equivalents 16,108 1,775 3,051 10,539 613
Restrictable Cash - - - - -
Marketable Securities 10,647 - - - -
Accounts Receivable 41 1,854 124 100 -
Loans Receivable - - - - -
Other Receivables 41 1,854 124 100 -
Receivables 41 1,854 124 100 -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 67 193 145 161 -
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 26,863 3,823 3,320 10,800 613
Land and Improvements - - - - -
Buildings and Improvement 50 - - - -
Machinery, Furniture and Equipment - - - - -
Construction in Progress - - - - -
Fixed Assets, Other - - 1 3 -
Fixed Assets, Total 50 - 1 3 -
Gross Fixed Assets 50 - 1 3 -
Accumulated Depreciation (2) - - - -
Net Fixed Assets 48 - 1 3 -
Intangibles 54 61 67 71 -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets - - - - -
Total Non-Current Assets 102 61 68 73 -
Total Assets 26,965 3,884 3,388 10,873 613
Liabilities [+] in Thousands of Dollars
03/2020 03/2019 03/2018 03/2017 12/2015
Accounts Payable 324 600 679 365 8
Short Term Debt 25 - - - -
Notes Payable - - - - -
Accrued Expenses 939 1,194 773 685 5
Accrued Liabilities 939 1,194 773 685 5
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - - 4,467 -
Total Current Liabilities 1,288 1,794 1,453 5,517 13
Long Term Debt N/A N/A N/A N/A -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - 131 261 358 -
Minority Interest - - - - -
Capital Lease Obligations 23 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 23 131 261 358 -
Total Liabilities 1,311 1,925 1,714 5,876 13
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 25,654 1,959 1,674 4,997 599
Common Par 40,151 12,439 11,077 10,108 -
Additional Paid in Capital 7,373 6,463 4,485 2,699 746
Cumulative Translation Adjustments - - - - -
Retained Earnings (22,047) (17,061) (14,004) (7,970) (146)
Treasury Stock - - - - -
Other Equity Adjustments 176 118 117 161 -
Total Capitalization 25,654 1,959 1,674 4,997 599
Total Equity 25,654 1,959 1,674 4,997 599
Total Liabilities & Shareholder's Equity 26,965 3,884 3,388 10,873 613
Cash Flow (5,874) (3,525) (5,782) (5,729) (146)
Working Capital 25,574 2,029 1,867 5,282 599
Free Cash Flow (6,355) (6,017) (7,841) (5,488) (35)
Invested Capital 25,654 1,959 1,674 4,997 599
Shares Outstanding - Common Class Only 46,800 28,578 24,578 24,313 1,071
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 33,212 21,395 19,036 18,253 774
Total Common Shares Outstanding 46,800 28,578 24,578 24,313 1,071
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 22,638 19,221 18,873 12,697 138
Diluted Weighted Shares Outstanding 22,638 19,221 18,873 12,697 138